Next in HIV Therapy
Over the past decades, there has been a lot of progress made in treating HIV/AIDS and the next step is close at hand. According to The Washington Post, a monthly antiretroviral shot is in development and could help to improve adherence to treatment. Currently, treatment consists of one or more pills daily, which has led to low adherence among some populations. The monthly injection combines 2 drugs, and a study involving 309 patients has found it to be as safe and effective as the daily pills.
Molina Healthcare Layoffs
Shake-ups are continuing at Molina Healthcare as the insurer announced it plans to cut 1400 jobs, reported Reuters. Molina specializes in programs for low-income and poor patients, and just a few months ago it had fired its CEO, J. Mario Molina, MD, and its chief financial officer (CFO), John C. Molina. In the fourth quarter of 2016, the company had reported a loss related to its Affordable Care Act plans, which kicked off the ensuing changes. The layoffs will not affect the company’s behavioral health business, said the interim CEO and CFO.
No US Treatment for Charlie Gard
The 11-month-old baby in London born with a rare genetic disease, Charlie Gard, will not be coming to the United States for treatment. STAT reported that the legal battle over how to proceed came to an end as the baby’s parents withdrew an appeal at a London court. Doctors at the hospital where he was wanted to turn off his life support and let him die peacefully. They had argued that there was no treatment that could help Gard and had challenged his parents’ wish to bring him to the United States for an experimental treatment.
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More